Literature DB >> 1649315

A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution.

M S Carpenter1, A M DeLange.   

Abstract

Using pulsed-field gel electrophoresis, we demonstrated that the temperature-sensitive (ts) conditional lethal mutant ts9383 is, at the nonpermissive temperature, defective in the resolution of concatemeric replicative intermediate DNA to linear 185-kb monomeric DNA genomes. The resolution defect was shown to be the result of a partial failure of the mutant virus to convert the replicated form of the viral telomere to hairpin termini. In contrast to other mutants of this phenotype, pulse-labeling of viral proteins at various times postinfection revealed no obvious difference in the quantity or temporal appearance of members of the late class of polypeptides. Using the marker rescue technique, we localized the ts lesion in ts9383 to an approximately 1-kb region within the HindIII D fragment. Both the ts phenotype and the resolution defect were shown to be caused by a single-base C----T point mutation resulting in the conversion of the amino acid proline to serine in codon 23 of open reading frame D12. This gene encodes a 33-kDa polypeptide which is known to be the small subunit of the virus-encoded mRNA capping enzyme (E. G. Niles, G. J. Lee-Chen, S. Shuman, B. Moss, and S. S. Broyles, Virology 172:513-522, 1989). The data are consistent with a role for this capping enzyme subunit during poxviral telomere resolution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649315      PMCID: PMC248835     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter.

Authors:  D Stuart; K Graham; M Schreiber; C Macaulay; G McFadden
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Biogenesis of vaccinia: complementation and recombination analysis of one group of conditional-lethal mutants defective in envelope self-assembly.

Authors:  J R Lake; M Silver; S Dales
Journal:  Virology       Date:  1979-07-15       Impact factor: 3.616

3.  Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.

Authors:  A Nagaya; B G Pogo; S Dales
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

4.  Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA.

Authors:  P Geshelin; K I Berns
Journal:  J Mol Biol       Date:  1974-10-05       Impact factor: 5.469

5.  Rifampicin: a specific inhibitor of vaccinia virus assembly.

Authors:  B Moss; E N Rosenblum; E Katz; P M Grimley
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

6.  Structure of the transcription initiation and termination sequences of seven early genes in the vaccinia virus HindIII D fragment.

Authors:  G J Lee-Chen; N Bourgeois; K Davidson; R C Condit; E G Niles
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

7.  Detailed phenotypic characterization of five temperature-sensitive mutants in the 22- and 147-kilodalton subunits of vaccinia virus DNA-dependent RNA polymerase.

Authors:  U Hooda-Dhingra; C L Thompson; R C Condit
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

9.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

10.  Formation of a vaccinia virus structural polypeptide from a higher molecular weight precursor: inhibition by rifampicin.

Authors:  E Katz; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1970-07       Impact factor: 11.205

View more
  15 in total

1.  Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.

Authors:  A D Garcia; B Moss
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

3.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

4.  In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease.

Authors:  D Stuart; K Ellison; K Graham; G McFadden
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  A yeast-based genetic system for functional analysis of viral mRNA capping enzymes.

Authors:  C K Ho; A Martins; S Shuman
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability.

Authors:  K S Ellison; W Peng; G McFadden
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 7.  Orthopoxvirus targets for the development of antiviral therapies.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Curr Drug Targets Infect Disord       Date:  2005-03

Review 8.  Reaching for the ring: the study of mitochondrial genome structure.

Authors:  A J Bendich
Journal:  Curr Genet       Date:  1993-10       Impact factor: 3.886

9.  Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Authors:  Olga Boyd; Audra L Strahl; Carson Rodeffer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

10.  Transcription of viral late genes is dependent on expression of the viral intermediate gene G8R in cells infected with an inducible conditional-lethal mutant vaccinia virus.

Authors:  Y Zhang; J G Keck; B Moss
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.